Home

Enliven Therapeutics, Inc. - Common Stock (ELVN)

20.30
+0.69 (3.52%)
NASDAQ · Last Trade: Oct 6th, 5:10 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END
Via FinancialNewsMedia · October 4, 2024